Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Gilead Sciences
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
A study is to see if HIV-1 positive subjects currently taking an antiretroviral (ARV) regimen consisting of EVG/COBI/FTC/TDF (E/C/F/TDF) STR, Atripla® (also known as Sustiva®), cobicistat and atazanavir with Truvada® or ritonovir and atazanavir with Truvada® can safely switch to E/C/F/TAF STR without increasing the amount of HIV-1 in their blood
The primary objective of this study is: • To evaluate the non-inferiority of switching to a TAF-Containing STR relative to maintaining TDF-Containing Regimens in Virologically-Suppressed HIV-1 positi...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
A Clinical trial to evaluate safety, and effectiveness of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis. Estudio para evaluar la seguridad y eficacia de selonsertib en pacientes con esteatohepatitis no alcohólica (EHNA) y fibrosis en puentes (F3)
The primary objective of this study is: To evaluate whether SEL can cause fibrosis regression and reduce progression to cirrhosis and associated complications in subjects with NASH and bridging (F3) f...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
A study evaluating the safety and efficacy of the combination of GS-4059 and idelalisib with and without obinutuzumab in subjects with chronic lymphocytic leukemia
The primary objective of this study is to determine the preliminary efficacy of the combination of GS-4059 and idelalisib with and without obinutuzumab in subjects with relapsed or refractory CLL
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
An Open-Label, Randomized, Phase 3 Trial to Evaluate the Efficacy and Safety of Aztreonam 75 mg Powder and Diluent for Nebulizer Solution (AZLI) versus Tobramycin Nebulizer Solution (TNS) in an Intermittent Aerosolized Antibiotic Regimen in Subjects with Cystic Fibrosis Followed by an Open-Label, Single-Arm Extension
To assess the comparative safety and efficacy of Aztreonam Lysine for Inhalation (AZLI) and Tobramycin Nebuliser Solution (TNS) in adult and pediatric cystic fibrosis (CF) patients with pulmonary Pseu...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
Study to evaluate the effects of a combination therapy of antiviral agents for the treatment of Hepatitis C Virus Infection
The primary objective of this study is to evaluate the antiviral efficacy (sustained virologic response [SVR]; defined as undetectable HCV RNA 24 weeks following treatment cessation) of 16 and 24 week...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences Incorporated
Update Il y a 4 ans
A Phase 1B Study of the Safety and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (GS-9137/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Treatment-Experienced Adolescents
To evaluate the steady-state pharmacokinetics (PK) and confirm the dose of ritonavirboosted elvitegravir (GS-9137/r) in HIV-1 infected antiretroviral treatment-experienced adolescent subjects.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
An investigation of the effectiveness and safety of Tenofovir Disoproxil Fumarate (TDF) given on its own versus Emtricitabine and TDF taken together in patients with long lasting Hepatitis B for whom lamivudine therapy has not been successful due to the virus becoming resistant to its action Investigación de la eficacia y seguridad de Tenofovir Disoproxil Fumarato (TDF) solo versus emtricitabina y TDF tomados juntos en pacientes con hepatitis B de larga duración en los cuales la terapia con lamivudina no ha tenido éxito y a que el virus ha llegado a ser resistente a su acción
? To compare the antiviral efficacy against hepatitis B virus (HBV) of once-daily tenofovir DF versus once-daily emtricitabine plus tenofovir DF combination treatment in subjects with lamivudine resis...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group Study to Evaluate the Efficacy and Safety of Fixed Doses of Darusentan in Subjects with Resistant Systolic Hypertension Receiving Combination Therapy with Three or More Antihypertensive Drugs, Including a Diuretic (Protocol DAR-311)
The primary objective of this study is to determine if darusentan is effective in reducing SBP in subjects with RHTN, despite treatment with full doses of three or more antihypertensive drugs, includi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
A Phase 3 Randomized, Open Label Study to Evaluate Switching from Regimens Consisting of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors to Emtricitabine/Rilpivirine/ Tenofovir Disoproxil Fumarate (FTC/RPV/TDF) Fixed-dose Regimen in Virologically Suppressed, HIV-1 Infected Patients. Estudio en fase 3 aleatorizado y abierto para evaluar el cambio de un tratamiento formado por un inhibidor de la proteasa reforzado con ritonavir y dos inhibidores de la transcriptasa inversa nucleosídicos por un tratamiento de dosis fijas con emtricitabina/rilpivirina/tenofovir disoproxil fumarato (FTC/RPV/TDF) en pacientes infectados por el VIH-1 con supresión virológica
Evaluar la ausencia de inferioridad de FTC/RPV/TDF con respecto a los regímenes que contienen un inhibidor de la proteasa reforzado con ritonavir (IP/r) y dos inhibidores de la transcriptasa inversa n...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 4 ans
A Long Term Study to Follow the Safety of a New Treatment in Patients with Crohn’s Disease
To observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in CD
Country
None
organs
None
Specialty
None
unknown
More information
Previous
8
9
10
11
12
13
14
15
16
17
Next